cellular biomedicine group

Recon

Josh SandbergJune 13, 2015
1,815

Cellular Biomedicine Group Announces Publication of Human Adipose-Derived Progenitor Cells to Treat Knee Osteoarthritis

SHANGHAI, China and PALO ALTO, Calif., June 5, 2015 (GLOBE NEWSWIRE) — Cellular Biomedicine Group Inc. (Nasdaq:CBMG) (“CBMG” or the…
Read More »
Uncategorized

Josh SandbergJune 8, 2015
1,662

Cellular Biomedicine Group Announces Publication of Human Adipose-Derived Progenitor Cells to Treat Knee Osteoarthritis

SHANGHAI, China and PALO ALTO, Calif., June 5, 2015 (GLOBE NEWSWIRE) — Cellular Biomedicine Group Inc. (Nasdaq:CBMG) (“CBMG” or the…
Read More »
Josh SandbergFebruary 27, 2014
706

Cellular Biomedicine Group Announces Updated Results From Phase I/IIa Clinical Trial for ReJoin(TM) Treatment of Knee Osteoarthritis (KOA)

PALO ALTO, Calif., Feb. 24, 2014 (GLOBE NEWSWIRE) — Cellular Biomedicine Group, Inc. (OTCQB:CBMG) today announced updated analysis of its…
Read More »